Io Biotech, Inc. (IOBT) — 10-Q Filings
All 10-Q filings from Io Biotech, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
IO Biotech Narrows Loss, Boosts Liquidity Amid Cash Burn
— Nov 14, 2025 Risk: high
IO Biotech, Inc. reported a net loss of $57.016 million for the nine months ended September 30, 2025, an improvement from a net loss of $64.158 million in the s -
IO Biotech's Cash Dwindles Amid Rising Losses, R&D Spend
— Aug 14, 2025 Risk: high
IO Biotech, Inc. reported a significant increase in net loss for the six months ended June 30, 2025, reaching $48.6 million, up from $40.1 million in the prior -
IO Biotech Files 10-Q: EIB Loan Facility and Stock Activity
— May 14, 2025 Risk: medium
IO Biotech, Inc. filed its 10-Q for the period ending March 31, 2025. The company's financial statements reflect activities related to its common stock, warrant -
IO Biotech Files 10-Q for Q3 2024
— Nov 12, 2024 Risk: medium
IO Biotech, Inc. filed its 10-Q for the period ending September 30, 2024. The company's fiscal year ends on December 31st. Key dates mentioned include November -
IO Biotech Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
IO Biotech, Inc. filed its Q2 2024 10-Q report on August 13, 2024, detailing financial activities for the period ending June 30, 2024. The company's fiscal year -
IO Biotech, Inc. Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk: low
IO Biotech, Inc. (IOBT) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. IO Biotech, Inc. filed a 10-Q for the period ending March 31, 2024. The co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX